Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli

Nephrology Dialysis Transplantation

Volumn 24, Issue 6, 2009, Pages 1744-1752

  Xu, Zhong Gao ^a   Miao, Li Ning ^a   Cui, Ying Chun ^a   Jia, Ye ^a   Yuan, Hang ^a   Wu, Man ^a  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

12(S) hydroxyeicosatetraenoic acid; 12 lipoxygenase; Angiotensin II type 1 receptor; Diabetic nephropathy; Glomeruli

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ANGIOTENSIN 1 RECEPTOR; ARACHIDONATE 12 LIPOXYGENASE; CINNAMYL 3,4 DIHYDROXY ALPHA CYNANOCINNAMATE; GLUCOSE; MESSENGER RNA; OXYGENASE INHIBITOR; STREPTOZOCIN; UNCLASSIFIED DRUG;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOWN REGULATION; GLOMERULUS; IMMUNOHISTOCHEMISTRY; KIDNEY HYPERTROPHY; LIPID DIET; MALE; MESANGIUM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORGAN SIZE; OSMOTIC MINIPUMP; PODOCYTE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; BASE SEQUENCE; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DNA PRIMERS; GENE EXPRESSION; GLUCOSE; HYPERTROPHY; KIDNEY GLOMERULUS; MALE; MESANGIAL CELLS; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PODOCYTES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 67651085473     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn703     Document Type: Article

References (44)

1. Chiu AT, Herblin WF, McCall DE et al. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989; 165: 196-203
2. Whitebread S, Mele M, Kamber B et al. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989; 163: 284-291
3. Opie LH. Renoprotection by angiotensin-receptor blockers and ACE inhibitors in hypertension. Lancet 2001; 358: 1829-1831
4. Burns KD. Angiotensin II and its receptors in the diabetic kidney. Am J Kidney Dis 2000; 36: 449-467
5. Xu ZG, Yuan H, Lanting L et al. Products of 12/15-lipoxygenase upregulate the angiotensin II receptor. Kidney Int 2006; 69: 512-519
6. Kang SW, Adler SG, Nast CC et al. 12-Lipoxygenase expression is increased in diabetic nephropathy. Kidney Int 2001; 59: 1354-1362
7. Reddy MA, Adler SG, Kim YS et al. Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells. Am J Physiol Renal Physiol 2002; 283: F985-F994
8. Xu ZG, Lanting L, Vaziri ND et al. Upregulation of angiotensin II type 1 receptor, inflammatory mediators and enzymes of arachidonate metabolism in obese Zucker rat kidney: reversal by angiotensin II type 1 receptor blockade. Circulation 2005; 111: 1962-1969
9. Hostetter TH. Prevention of end-stage renal disease due to type 2 diabetes. N Engl J Med 2001; 345: 910-912
10. Volpini RA, Da Silva CG, Costa RS et al. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats. Diabetes Metab 2003; 19: 43-51
11. Amiri F, Garcia R. Regulation of angiotensin II receptors and PKC isoforms by glucose in rat mesangial cells. Am J Physiol Renal Physiol 1999; 45: F691-F699
12. Amiri F, Garcia R. Renal angiotensin II receptors and protein kinase C in diabetic rats: effects of insulin and ACE inhibition. Am J Physiol Renal Physiol 2000; 45: F603-F612
13. Chouinard RF, Meek RL, Cooney SK et al. Effects of amino acids and glucose on mesangial cell aminopeptidase a and angiotensin receptors. Kidney Int. 2002; 61(Supp 11 s): S106-S109
14. Neckenig G, Harrison DG. The AT1-type angiotensin receptor in oxidative stress and atherogenesis Part II: AT1 receptor regulation. Circulation 2002; 105: 530-536
15. Ichiki T, Usui M, Kato M et al. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension 1998; 31: 342-348
16. Kreisberg JI, Karnovsky MJ. Glomerular cells in culture. Kidney Int 1983; 23: 439-447
17. Wolf G, Haberstroh U, Neilson EG. Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 1992; 140: 95-107
18. Kim YS, Lanting L, Adler SG et al. Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice. Kidney Int 2003; 64: 1702-1714
19. Mundel P, Reiser J, Zúñiga Mejía Borja A et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 1997; 236: 248-258
20. Lin KY, Ito A, Asagami T et al. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 2002; 106: 987-992
21. Danda RS, Habiba NM, Rincon-Choles H et al. Kidney involvement in a nongenetic rat model of type 2 diabetes. Kidney Int 2005; 68: 2562-2571
22. Ma J, Natarajan R, LaPage J et al. 12/15-Lipoxygenase inhibitors in diabetic nephropathy in the rat. Prostaglandins Leukot Essent Fatty Acids 2005; 72: 13-20
23. Li B, Yao J, Kawamura K et al. Real-time observation of glomerular hemodynamic changes in diabeticrats: effects of insulin and ARB. Kidney Int 2004; 66: 1939-1948
24. Hoffmann S, Podlich D, Hahnel B et al. Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 2004; 15: 1475-1487
25. Ballermann BJ, Skorecki KL, Brenner BM. Reduced glomerular angiotensin II receptor density in early untreated diabetes mellitus in the rat. Am J Physiol 1984; 247: F110-F116
26. Wilkes BM. Reduced glomerular angiotensin II receptor density in diabetes mellitus in the rat: time course and mechanism. Endocrinology 1987; 120: 1291-1298
27. Brown L, Wall D, Marchant C et al. Tissue-specific changes in angiotensin II receptors in streptozotocin-diabetic rats. J Endocrinol 1997; 154: 355-362
28. Bonnet F, Candido R, Carey RM et al. Renal expression of angiotensin receptors in long-term diabetes and effects of angiotensin type 1 receptor blockade. J Hypertens 2002; 20: 1615-1624
29. Mezzano S, Droguett A, Burgos ME et al. Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int 2003; 64(Suppl 86s): S64-S70
30. Harrison-Bernard LM, Imig JD, Carmines PK. Renal AT1 receptor protein expression during the early stage of diabetes mellitus. Int J Exp Diabetes Res 2002; 3: 97-108
31. Becker M, Umrani D, Lokhandwala MF et al. Increased renal angiotensin II AT1 receptor function in obese Zucker rat. Clin Exp Hypertens 2003; 25: 35-47
32. Hussain T. Renal angiotensin II receptors, hyperinsulinemia and obesity. Clin Exp Hypertens 2003; 25: 395-403
33. Nobrega MA, Fleming S, Roman RJ et al. Initial characterization of a rat model of diabetic nephropathy. Diabetes 2004; 53: 735-742
34. Janssen U, Phillips AO, Floege J. Rodent models of nephropathy associated with type II diabetes. J Nephrol 1999; 12: 159-172
35. Vora JP, Zimsen SM, Houghton DC et al. Evolution of metabolic and renal changes in the ZDF/Drt-fa rat model of type II diabetes. JAm Soc Nephrol 1996; 7: 113-117
36. Bennett RA, Pegg AE. Alkylation of DNA in rat tissues following administration of streptozotocin. Cancer Res 1981; 41: 2786-2790
37. Bolzan AD, Blanchi MS. Genotoxicity of streptozotocin. Mutat Res 2002; 512: 121-134
38. Kraynak AR, Storer RD, Jensen RD et al. Extent and persistence of streptozotocin-induced DNA damage and cell proliferation in rat kidney as determined by in vivo alkaline elution and BrdUrd labeling assays. Toxicol Appl Pharmacol 1995; 135: 279-286
39. Gross ML, Ritz E, Schoof A et al. Comparison of renal morphology in the streptozotocin and the SHR/N-cp models of diabetes. Lab Invest 2004; 84: 452-464
40. Sharma K. Structural and functional consequences of streptozotocin- induced diabetes on the kidney. Experimental Models of Diabetes. Boca Raton, FL: CRC Press LLC, 1999
41. Anderson PW, Zhang XY, Tian J et al. Insulin and angiotensin II are additive in stimulating TGF-beta and matrix mRNAs in mesangial cells. Kidney Int 1996; 50: 745-753
42. Nickenig G, Roling J, Strehlow K et al. Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms. Circulation 1998; 98: 2453-2460
43. Kim YS, Xu ZG, Reddy MA et al. Novel Interactions between TGF-{beta} 1 actions and the 12/15-lipoxygenase pathway in mesangial cells. J Am Soc Nephrol 2005; 16: 352-362
44. Xu ZG, Li SL, Lanting L et al. Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy. Kidney Int 2006; 69: 512-519